Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Shoag J, Liu D, Blattner M, Sboner A, Park K, Deonarine L, et al. SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. J Clin Invest. 2018;128(1):381-386.

Lu X, Fernando TM, Lossos C, Yusufova N, Liu F, Fontan L, et al. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival. Blood. 2018;132(19):2026-2039.

Han L, Zheng W, Zhai Y, Xie X, Zhang J, Zhang S, et al. Reference intervals of trimester-specific thyroid stimulating hormone and free thyroxine in Chinese women established by experimental and statistical methods. J Clin Lab Anal. 2018;32(4):e22344.

Goyal A, Sharaiha RZ, Alperstein SA, Siddiqui MT. Cytologic diagnosis of adenocarcinoma on bile duct brushings in the presence of stent associated changes: A retrospective analysis. Diagn Cytopathol. 2018;46(10):826-832.

Rickman DS, Schulte JH, Eilers M. The Expanding World of N-MYC-Driven Tumors. Cancer Discov. 2018;8(2):150-163.

Iyengar NM, Chen I-, Zhou XK, Giri DD, Falcone DJ, Winston LA, et al. Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian Women. Cancer Prev Res (Phila). 2018;11(4):227-236.

Alperstein S, Dilcher T, Viswanathan K, Rao RA, Siddiqui MT, Giorgadze T. Acquired myospherulosis secondary to gluteal augmentation on fine needle aspiration cytology: A diagnostic challenge. Diagn Cytopathol. 2018;46(5):438-442.

Chapman J, Geyer JT, Khanlari M, Moul A, Casas C, Connor ST, et al. Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia. Mod Pathol. 2018;31(3):429-441.

Snodgrass R, Gardner A, Semeere A, Kopparthy VL, Duru J, Maurer T, et al. A portable device for nucleic acid quantification powered by sunlight, a flame or electricity. Nat Biomed Eng. 2018;2(9):657-665.

Sowalsky AG, Ye H, Bhasin M, Van Allen EM, Loda M, Lis RT, et al. Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations. Cancer Res. 2018;78(16):4716-4730.